Page last updated: 2024-11-10

argipressin, beta-mercapto beta,beta-cyclopentamethylenepropionic acid(1)-o-methyl-tyr(2)-val(4)-

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

argipressin, beta-mercapto beta,beta-cyclopentamethylenepropionic acid(1)-O-methyl-Tyr(2)-Val(4)-: vasopressin antagonist [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID3086072
CHEMBL ID2370971
MeSH IDM0092558

Synonyms (11)

Synonym
d(ch2)5tyr(me)vavp
argipressin, beta-mercapto beta,beta cyclopentamethylenepropionic acid(1)-o-methyltyrosyl(2)-valine(4)-
arginine vasopressin, beta-mercato-beta,beta-cyclopentamethylenepropionic acid(1)-o-methyl-tyr(2)-val(4)-
d(ch2)5tyr(me)vdavp
1-(mercapto-beta,beta-cyclopentamethylenepropionic acid)-2-(o-methyl-tyr)-4-val-argipressin
vasopressin, 1-(1-mercaptocyclohexaneacetic acid)-2-(o-methyl-l-tyrosine)-4-l-valine-8-l-arginine-
77403-97-5
argipressin, beta-mercapto beta,beta-cyclopentamethylenepropionic acid(1)-o-methyl-tyr(2)-val(4)-
CHEMBL2370971
DTXSID50228116
(2s)-n-[(2s)-1-[(2-amino-2-oxoethyl)amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]-1-[(10r,13s,16s,19s,22s)-13-(2-amino-2-oxoethyl)-19-benzyl-22-[(4-methoxyphenyl)methyl]-12,15,18,21,24-pentaoxo-16-propan-2-yl-7,8-dithia-11,14,17,20,23-pentazaspiro[

Research Excerpts

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (8)

Assay IDTitleYearJournalArticle
AID197001In vivo pA2 value represent the negative logarithm of the effective dose divided by the estimated volume of distribution (67 mL/kg).1982Journal of medicinal chemistry, Jan, Volume: 25, Issue:1
Design of more potent antagonists of the antidiuretic responses to arginine-vasopressin.
AID196974In vitro anti-oxytocic potency was evaluated in the absence of Mg2+1985Journal of medicinal chemistry, Oct, Volume: 28, Issue:10
Synthesis and some pharmacological properties of 18 potent O-alkyltyrosine-substituted antagonists of the vasopressor responses to arginine-vasopressin.
AID196995In vivo anti-vasopressor activity measured as the negative logarithm of the effective dose / the estimated volume of distribution (67 mL/kg)1985Journal of medicinal chemistry, Oct, Volume: 28, Issue:10
Synthesis and some pharmacological properties of 18 potent O-alkyltyrosine-substituted antagonists of the vasopressor responses to arginine-vasopressin.
AID179640Effective dose is defined as the dose that reduces the response seen with 2 units of agonist to equal the response seen with 1 unit of agonist administered before antagonist.1982Journal of medicinal chemistry, Jan, Volume: 25, Issue:1
Design of more potent antagonists of the antidiuretic responses to arginine-vasopressin.
AID168767Antidiuretic activity was evaluated for the compound in rats under ethanol anesthesia; Antagonist1985Journal of medicinal chemistry, Oct, Volume: 28, Issue:10
Synthesis and some pharmacological properties of 18 potent O-alkyltyrosine-substituted antagonists of the vasopressor responses to arginine-vasopressin.
AID179497Antivasopressor effective dose is defined as the dose that reduces the response seen with 2 units of agonist to equal the response seen with 1 unit of agonist administered before antagonist.1982Journal of medicinal chemistry, Jan, Volume: 25, Issue:1
Design of more potent antagonists of the antidiuretic responses to arginine-vasopressin.
AID196975In vitro anti-oxytocic potency was evaluated in the presence of 0.5 mM of Mg2+1985Journal of medicinal chemistry, Oct, Volume: 28, Issue:10
Synthesis and some pharmacological properties of 18 potent O-alkyltyrosine-substituted antagonists of the vasopressor responses to arginine-vasopressin.
AID173439In vivo anti-vasopressor activity measured as effective dose that reduces the response to 2x units of agonist to equal the response to 1x unit1985Journal of medicinal chemistry, Oct, Volume: 28, Issue:10
Synthesis and some pharmacological properties of 18 potent O-alkyltyrosine-substituted antagonists of the vasopressor responses to arginine-vasopressin.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (14)

TimeframeStudies, This Drug (%)All Drugs %
pre-19908 (57.14)18.7374
1990's4 (28.57)18.2507
2000's2 (14.29)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.43

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.43 (24.57)
Research Supply Index2.71 (2.92)
Research Growth Index4.14 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.43)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other14 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]